This correspondence addresses the relevance of bile VEGF as a potential biomarker in malignant biliary stenosis.
Discussion on existing data regarding bile VEGF and its implications in clinical practice.
Suggests that bile VEGF may indicate clinical outcomes in patients with malignant biliary stenosis.
Abstract
The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.